Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Monday, July 21, 2014

In this Q&A and video, medical oncologist Mark Dickson discusses his approach to treating sarcoma and melanoma and how he develops individual treatment plans for each patient.

Pictured: William Tap
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Monday, July 14, 2014

In this Q&A, medical oncologist William Tap describes Memorial Sloan Kettering’s expertise in providing cutting-edge treatment for people with different types of soft tissue sarcoma.

Pictured: William Tap
MSK at ASCO
By Media Staff  |  Thursday, May 15, 2014

New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.

Pictured: Sandra D’Angelo
Video
By Memorial Sloan Kettering  |  Friday, March 21, 2014

Medical oncologist Sandra D’Angelo, who specializes in caring for patients with rare cancers such as melanoma, soft tissue sarcoma, and Merkel cell carcinoma, talks about the team approach and the importance of empowering patients.

Pictured: George Plitas
Perspective
By George Plitas, MD  |  Friday, March 14, 2014

The correct identification and naming of a tumor’s type is increasingly important in the era of personalized medicine, and tumors that exhibit features of more than one type can complicate that process.

Pictured: William Tap
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Wednesday, January 29, 2014

We offer unparalleled expertise in understanding and treating the more than 70 subtypes of soft tissue sarcoma identified to date.

Pictured: Mrinal Gounder
Video
By Memorial Sloan Kettering  |  Monday, January 13, 2014

Medical oncologist Mrinal Gounder describes our sophisticated and multidisciplinary approach to care for patients with sarcomas of the soft tissue and bone.

Pictured: Guido Dalbagni
Video
By Memorial Sloan Kettering  |  Tuesday, April 23, 2013

Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan Kettering, which can help patients maintain their quality of life.

Pictured: Gary Schwartz & Mark Dickson
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 22, 2013

Two clinical trials of targeted therapies led by Memorial Sloan Kettering investigators show promising results against different types of sarcoma.

Pictured: Ron Kraemer
Patient Story
By Memorial Sloan Kettering  |  Friday, March 22, 2013

To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan Kettering for care and support that could keep him playing music and working as a personal fitness trainer.

Pictured: Ping Chi
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Friday, November 2, 2012

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Feature
By Jim Stallard, MA and Julie Grisham, MS
Friday, September 21, 2012

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.